 Anti-Bacterial Agents
"Anti-Bacterial Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that inhibit the growth or reproduction of BACTERIA.
| Descriptor ID |
D000900
|
| MeSH Number(s) |
D27.505.954.122.085
|
| Concept/Terms |
Anti-Bacterial Agents- Anti-Bacterial Agents
- Agents, Anti-Bacterial
- Anti Bacterial Agents
- Antibacterial Agents
- Agents, Antibacterial
- Anti-Bacterial Compounds
- Anti Bacterial Compounds
- Compounds, Anti-Bacterial
Anti-Mycobacterial Agents- Anti-Mycobacterial Agents
- Agents, Anti-Mycobacterial
- Anti Mycobacterial Agents
- Antimycobacterial Agents
- Agents, Antimycobacterial
|
Below are MeSH descriptors whose meaning is more general than "Anti-Bacterial Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Bacterial Agents".
This graph shows the total number of publications written about "Anti-Bacterial Agents" by people in this website by year, and whether "Anti-Bacterial Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 4 | 1 | 5 | | 1996 | 2 | 4 | 6 | | 1997 | 4 | 1 | 5 | | 1998 | 6 | 4 | 10 | | 1999 | 11 | 5 | 16 | | 2000 | 3 | 3 | 6 | | 2001 | 8 | 3 | 11 | | 2002 | 4 | 3 | 7 | | 2003 | 11 | 10 | 21 | | 2004 | 10 | 6 | 16 | | 2005 | 7 | 11 | 18 | | 2006 | 10 | 6 | 16 | | 2007 | 11 | 10 | 21 | | 2008 | 18 | 14 | 32 | | 2009 | 11 | 15 | 26 | | 2010 | 20 | 14 | 34 | | 2011 | 28 | 11 | 39 | | 2012 | 21 | 16 | 37 | | 2013 | 30 | 14 | 44 | | 2014 | 28 | 14 | 42 | | 2015 | 41 | 22 | 63 | | 2016 | 37 | 23 | 60 | | 2017 | 38 | 16 | 54 | | 2018 | 48 | 22 | 70 | | 2019 | 54 | 26 | 80 | | 2020 | 43 | 44 | 87 | | 2021 | 39 | 54 | 93 | | 2022 | 11 | 69 | 80 | | 2023 | 16 | 57 | 73 | | 2024 | 37 | 45 | 82 | | 2025 | 19 | 5 | 24 |
To return to the timeline, click here.
Below are the most recent publications written about "Anti-Bacterial Agents" by people in Profiles.
-
Weissman GE, Hubbard RA, Himes BE, Goodman-O'Leary KL, Harhay MO, Ginestra JC, Kohn R, Admon AJ, Taylor SP, Halpern SD. Sepsis Prediction Models are Trained on Labels that Diverge from Clinician-Recommended Treatment Times. AMIA Annu Symp Proc. 2024; 2024:1215-1224.
-
Craig A, Shihadeh KC, Knepper BC, Miller W, Young HL, Aragon D, Jenkins TC. Antibiotic adherence and treatment completion associated with partial oral therapy versus all intravenous therapy in patients with serious Staphylococcus aureus infections. BMC Infect Dis. 2025 May 17; 25(1):714.
-
Lu D, Kalantar KL, Glascock AL, Chu VT, Guerrero ES, Bernick N, Butcher X, Ewing K, Fahsbender E, Holmes O, Hoops E, Jones AE, Lim R, McCanny S, Reynoso L, Rosario K, Tang J, Valenzuela O, Mourani PM, Pickering AJ, Raphenya AR, Alcock BP, McArthur AG, Langelier CR. Simultaneous detection of pathogens and antimicrobial resistance genes with the open source, cloud-based, CZ ID platform. Genome Med. 2025 May 06; 17(1):46.
-
Singh N, Dangi B, Johnson JJ, Louie A, Karunanidhi A, Curry BN, Mitarai S, Daley CL, Hobbie SN, Bulman ZP. Pharmacodynamic assessment of apramycin against Mycobacterium abscessus in a hollow fibre infection model. J Antimicrob Chemother. 2025 May 02; 80(5):1309-1314.
-
Morimoto K, Daley CL. Comprehensive Management Algorithm for Mycobacterium avium Complex Pulmonary Disease in the Real-World Setting. Ann Am Thorac Soc. 2025 May; 22(5):651-659.
-
Frappa KE, Fabbri S, Rockhill KM, Shihadeh KC, Jenkins TC, McClelland S. Penicillin allergies and selection of intrapartum antibiotic prophylaxis against group B Streptococcus at a safety-net institution. J Perinat Med. 2025 Jun 26; 53(5):624-629.
-
Forster CS, Wood AC, Davis-Rodriguez S, Desai S, Chang PW, Tchou MJ, Morrison JM, Hamdy RF, Vemulakonda V, Brady PW, Abou Zeid C, Wallace SS. Variability in Treatment of UTIs in Children With Genitourinary Anomalies in Children's Hospitals. Hosp Pediatr. 2025 Apr 01; 15(4):309-317.
-
Patterson JK, Neuwahl S, Kirsch S, Moore JL, Tita ATN, Carlo WA, Lokangaka A, Tshefu A, Mwenechanya M, Chomba E, Kavi A, Metgud MC, Goudar SS, Derman RJ, Shivkumar P, Waikar M, Patel A, Hibberd PL, Nyongesa P, Esamai F, Ekhaguere OA, Bucher S, Jessani S, Tikmani SS, Saleem S, Wylie BJ, Goldenberg RL, Billah SM, Lennox R, Haque R, Petri WA, Mazariegos M, Krebs NF, Hemingway-Foday JJ, Babineau D, Koso-Thomas M, McClure EM, Bauserman M. Cost-effectiveness of intrapartum azithromycin to prevent maternal infection, sepsis, or death in low-income and middle-income countries: a modelling analysis of data from a randomised, multicentre, placebo-controlled trial. Lancet Glob Health. 2025 Apr; 13(4):e679-e688.
-
Carlo WA, Tita ATN, Moore JL, Mwenechanya M, Chomba E, Hemingway-Foday JJ, Kavi A, Metgud MC, Goudar SS, Derman RJ, Lokangaka A, Tshefu A, Bauserman M, Patterson JK, Shivkumar P, Waikar M, Patel A, Hibberd PL, Nyongesa P, Esamai F, Ekhaguere OA, Bucher S, Jessani S, Tikmani SS, Saleem S, Goldenberg RL, Billah SM, Lennox R, Haque R, Petri W, Mazariegos M, Krebs NF, Babineau DC, McClure EM, Koso-Thomas M. Effectiveness of intrapartum azithromycin to prevent infections in planned vaginal births in low-income and middle-income countries: a post-hoc analysis of data from a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Glob Health. 2025 Apr; 13(4):e689-e697.
-
Kaplan JB, Muzaleva A, Sailer M, Huizinga RB, Kridin K. Synergistic activity of dispersin B and benzoyl peroxide against Cutibacterium acnes/Staphylococcus epidermidis dual-species biofilms. PLoS One. 2025; 20(3):e0320662.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|